Who is sponsoring NCT03854539?

NCT03854539 is sponsored by Arkansas Tech University.

What drugs are being tested in NCT03854539?

Interventions in NCT03854539: Transdermal Vagus Nerve Stimulation.

What condition does NCT03854539 study?

NCT03854539 studies No Condition Salivary Alpha Amylase.

Is NCT03854539 still recruiting?

NCT03854539 is currently completed. Last updated 18 June 2020.

Last reviewed 2020-06-18 · How we verify

NCT03854539

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Salivary Alpha Amylase as a Biomarker of Transdermal Vagus Nerve Stimulation

Completed NA Last updated 18 June 2020

What this trial tests

NA trial testing Transdermal Vagus Nerve Stimulation in No Condition Salivary Alpha Amylase in 100 participants. Completed in 8 June 2020.

Timeline

31 March 2018

Primary endpoint
8 June 2020

8 June 2020

Quick facts

Lead sponsor	Arkansas Tech University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	basic science
Enrollment	100
Start date	31 March 2018
Primary completion	8 June 2020
Estimated completion	8 June 2020
Sites	1 location across United States

Drugs / interventions tested

Transdermal Vagus Nerve Stimulation

Conditions studied

No Condition Salivary Alpha Amylase — all drugs for No Condition Salivary Alpha Amylase →

Sponsor

Arkansas Tech University

Who can join

18 and older, any sex, with No Condition Salivary Alpha Amylase. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The proposed project tests the hypothesis that salivary alpha amylase concentration is a reliable biomarker of the effect of transdermal vagus nerve stimulation (tVNS) in humans.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Arkansas Tech University trials

Trials by the same sponsor.

NCT04455295 — Testing the Noradrenergic Hypothesis of Transcutaneous Vagus Nerve Stimulation · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03854539 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Arkansas Tech University
Last refreshed: 18 June 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03854539.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing